NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. - Wikidata - awgldk - TriplyDB

NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

http://www.wikidata.org/entity/Q33565598

about

New means to assess neonatal inflammatory brain injury Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration Mammalian target of rapamycin complex 1 activation negatively regulates Polo-like kinase 2-mediated homeostatic compensation following neonatal seizures.Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice Pathophysiology of glia in perinatal white matter injury.The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.Neonatal seizures: an update on mechanisms and management Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia.The challenge of understanding cerebral white matter injury in the premature infant.Functional and histologic changes after repeated transcranial direct current stimulation in rat stroke model Pathophysiologic cascades in ischemic stroke HIP/PAP prevents excitotoxic neuronal death and promotes plasticity.Altered glutamatergic metabolism associated with punctate white matter lesions in preterm infants Oligodendrocyte plasticity with an intact cell body in vitro.The developing oligodendrocyte: key cellular target in brain injury in the premature infant Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain Animal models of periventricular leukomalacia.L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brain Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human.Glutamate receptors: the cause or cure in perinatal white matter injury?The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain.White matter protection in congenital heart surgery.Education of a child neurologist: developmental neuroscience relevant to child neurology.Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination Roles of white matter in central nervous system pathophysiologies.Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development.Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation.Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine.Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury.Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.LPS and TNF alpha modulate AMPA/NMDA receptor subunit expression and induce PGE2 and glutamate release in preterm fetal ovine mixed glial cultures.Neuroprotection in the newborn infant Endoplasmic reticulum stress, inflammation, and perinatal brain damage From selective vulnerability to connectivity: insights from newborn brain imaging.Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats

P2860

Q26786753-71BA7359-231E-42BA-894E-F3AF4C77D7E5 Q26851808-FE8FAF7F-214D-41BC-B176-2C65BC8679F5 Q27000069-BBF31843-564E-4147-9CB0-E6FFF00EAFFE Q28567546-A011B108-B7C5-484E-9E60-0416D8823A8A Q28580426-C2BAC455-9927-411D-BA47-134908AD88C8 Q30538200-3C3FE0ED-80B0-41DE-9928-2BD6C4027197 Q30585962-95F5D68E-4114-4F63-85FC-22F37D47CDBC Q30790294-5D38BED4-1E3C-4DE4-9BD7-A98F253CCB0B Q33516828-000DF9A0-86DF-496B-AB1A-C2A50ABF236D Q33639690-660A0F1E-705A-4B83-B907-98FA8622EF81 Q34042991-42851EA3-A426-4D23-83CB-96A84A1E0E1D Q34098352-301E3668-C3BE-477B-B88F-013992E7AC7B Q34159766-B38AAE77-D354-49C5-88FB-69E444A9F9A3 Q34282729-E464C869-9FBD-4FDC-8A78-71ED330EDC1B Q34562834-003DC126-9FB7-4C08-926F-3025B861AB4D Q34611606-ED7C17EA-6B00-4717-8645-101F76AD520D Q34770493-20B89B28-1A04-46B8-9A46-C7F114A383AE Q34995998-426B9599-3165-44B3-B229-74B158892DAC Q35003575-4364B4F6-6B47-4DEF-86AA-A05AB1AF90C3 Q35134958-6D9F7B73-3454-4CC8-8C42-BED0709A4870 Q35143473-7F7A6468-671F-494F-B6B6-9FF83BD54E6C Q35576382-E72651B2-7A90-4DF7-880E-43CDECC01D36 Q35632609-987DA60C-5963-40CC-841D-B44EA0167B85 Q35764182-D1AD0B8D-6C23-4702-9136-30A7F640F1EF Q35783776-779ABB8C-8AFC-4583-86DC-591EF1C20648 Q35789190-CC3910CB-EFA9-40AE-9011-1E98F3FE8600 Q35815842-2080D5A5-3CFB-474B-BE0D-4D810B61FA34 Q35846494-A1F6D2F7-2C7A-4F5E-9ACF-209A0C6D1E7D Q36112101-0FBDF84A-6E6C-4B50-ABAD-BA16ADB88BB3 Q36717752-E41B062F-D847-41E2-AB4F-0687948F6469 Q37227959-C4160BEC-23C9-4EBB-BE00-C5D7123A0723 Q37253850-7D9AAD40-2625-4F36-9BCA-48CEEFF39927 Q37319542-60DB0E2F-4BFD-4693-84F1-0E640C244C94 Q37396967-E4579691-B6AD-4699-9623-AE59D0B550C3 Q37409435-4532E7C6-6C59-47BB-8E58-7ABB106AF548 Q37426506-550563B2-31C2-4860-8A60-61C4574B7AB4 Q37452432-C0C8D762-C47D-4EA3-9FA5-1A0AA2CCECF2 Q37577306-A767E40F-D2C3-4661-A99C-B4DF55E1F1E4 Q37588245-D88F3B8B-407B-4AB4-86F7-48FAF83590FA Q37625047-78011BA5-EFF6-4A7F-A5BA-EF617A001770

P2860

NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

http://www.wikidata.org/entity/Q33565598

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

NMDA receptor blockade with me ...... periventricular leukomalacia.

@ast

NMDA receptor blockade with me ...... periventricular leukomalacia.

@en

NMDA receptor blockade with me ...... periventricular leukomalacia.

@nl

type

label

NMDA receptor blockade with me ...... periventricular leukomalacia.

@ast

NMDA receptor blockade with me ...... periventricular leukomalacia.

@en

NMDA receptor blockade with me ...... periventricular leukomalacia.

@nl

prefLabel

NMDA receptor blockade with me ...... periventricular leukomalacia.

@ast

NMDA receptor blockade with me ...... periventricular leukomalacia.

@en

NMDA receptor blockade with me ...... periventricular leukomalacia.

@nl

P1433

Q33565598-9D4AAE78-CE72-41B3-8618-7BEF445CCCB4

P1476

Q33565598-50155820-C134-40F2-BEF7-423A4917EFCE

P2093

Q33565598-2D421940-A986-4812-A1E6-676414A4ACBA

Q33565598-483B23AA-73BF-4F7F-A30E-C81BCA014188

Q33565598-4B7E954B-72EB-4B33-8AC6-12666C00E23B

Q33565598-93077B92-BD5E-4FA8-8191-56F103778A0B

Q33565598-B5987A6A-7546-4DB1-B9CC-C857F415DE79

Q33565598-BEA8FF44-4C24-4CFD-B971-DC01E867D4C4

Q33565598-D1ECAA3F-A586-427D-B9B9-FA0EE3543012

Q33565598-FE270BC6-D072-45B7-8ECA-1D2E60A8158A

P2860

Q33565598-012BD0E8-678E-4E56-A618-D016A7CDF80D

Q33565598-0A722E86-5F07-415A-AE6D-2435563A31EC

Q33565598-0C04E39D-3D94-4933-BF03-24D4AF3AA378

Q33565598-1DD2AFD2-6728-4C76-B53B-280BF53D7184

Q33565598-1F100A0C-4CB0-4433-BB53-1852121F5E43

Q33565598-1FADF940-FACD-4633-9FBD-9D8DD871AC05

Q33565598-25DFD7E1-15B6-44B9-BB47-5995E28FD3F7

Q33565598-28716858-78FB-41EB-967D-C0C89E22A238

Q33565598-2E211271-AECF-4A8F-BC4E-826D573B44EB

Q33565598-3C6CCE53-4FAD-4515-B82B-9F5705B9E8FF

P304

Q33565598-EC0ECC85-5D9D-4256-BC69-1E65546213BF

P31

Q33565598-1A648882-BD71-496C-BFCD-CD6195B7E142

P356

Q33565598-37CB1507-E84F-4D2F-8BD3-8AED36AD16C4

P407

Q33565598-901ED990-B7E8-4164-AEDD-217F3D8692F4

P433

Q33565598-BBEE931C-C6F3-4E9D-B421-5241F435CACC

P478

Q33565598-CAD000FF-3701-47EF-919D-F76207D2AD14

P577

Q33565598-E5B56B5D-F387-41D9-8FC6-570EA236AEA4

P698

Q33565598-C0507FCC-9A3A-45FE-9E88-387230A80077

P932

Q33565598-5696367C-6E63-4A6B-8665-1010C8E71FD1

P356

JNEUROSCI.1702-08.2008

P1433

Journal of Neuroscience

P1476

NMDA receptor blockade with me ...... periventricular leukomalacia.

@en

P2093

Chang-Joo Park

http://www.w3.org/2001/XMLSchema#string

Chengwen Zhou

http://www.w3.org/2001/XMLSchema#string

Debra B Selip

http://www.w3.org/2001/XMLSchema#string

Delia M Talos

http://www.w3.org/2001/XMLSchema#string

Frances E Jensen

http://www.w3.org/2001/XMLSchema#string

Hyun-Kyung Park

http://www.w3.org/2001/XMLSchema#string

Joseph J Volpe

http://www.w3.org/2001/XMLSchema#string

Simon M Manning

http://www.w3.org/2001/XMLSchema#string

P2860

The chemical biology of clinically tolerated NMDA receptor antagonists

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

Encephalopathy of prematurity includes neuronal abnormalities.

Non-N-methyl-D-aspartate glutamate receptors mediate oxygen--glucose deprivation-induced oligodendroglial injury.

Antagonists selective for NMDA receptors containing the NR2B subunit.

NMDA receptor subunits: diversity, development and disease.

Excitotoxic cell death.

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity.

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex.

P304

6670-6678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.1702-08.2008

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18579741

http://www.w3.org/2001/XMLSchema#string

P932

2800040

http://www.w3.org/2001/XMLSchema#string